124 EUR
7.8
5.92%
Last update Dec 17, 4:33 PM CET
Market closed
Day range
124
124
Previous close
131.80000
Open
124
Access this stock data via API
Subscribe
Neurocrine Biosciences Inc.
124.00
7.80
5.92%

Statistics

Valuation metrics
Market cap
0
Enterprise value
0
Trailing P/E (ttm)
36.47
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
0
Enterprise Value/EBITDA
0
Overview
Shares outstanding
99.70M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
28
Average volume (90 days)
17
Price summary
52-Week low
77.30
52-Week high
148.65
52-Week change
-4.32 -5.6%
Beta
50-Day moving average
124.86
200-Day moving average
111.94
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
98.56%
Operating margin
26.01%
Operational effectiveness
Return on assets
9.18%
Return on equity
13.18%
Income statement
Revenue (ttm)
2.01B
Revenue per share (ttm)
23.46
Quarterly revenue growth (yoy)
15.62%
Gross profit (ttm)
1.98B
EBITDA
428.21M
Net income to common (ttm)
290.95M
Diluted EPS (ttm)
3.29
Quarterly earnings growth (yoy)
26.00%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
0
Total Debt/Equity (mrq)
0
Current ratio (mrq)
338.31%
Book value per share (mrq)
Cash flow
Cash flow statement
473.56M
Levered free cash flow (LFCF)
290.95M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 11 minutes

07:48
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).